Autologous Adipose-Derived Adult Stromal Vascular Cell Administration for

Status Enrolling by invitation

Clinical Trial Summary

Severe Oligospermia (oligozoospermia) refer to semen with a low concentration of sperm and is a common finding in male infertility. Often semen with a decreased sperm concentration may also show significant abnormalities in sperm morphology and motility that affect Male fertility. The purpose of this study is to assess the ability of Autologous Adipose-Derived Adult Stromal Vascular Fraction (SVF) cells to stimulate Sertoli and spermatogonia cells and affect male fertility.

Clinical Trial Description

This is an open-label study to evaluate efficiency of administration of Autologous Adipose-Derived Adult Stromal Vascular Fraction (SVF) in the testis in patients with oligospermia and azoospermia. Forty men with several form oligozoospermia and azoospermia will be recruited for the study. 20 patients with same diagnosis served as a control with standard medications.Other patients -10 with oligospermia and 10 with azoospermia will receive standard medication and SVF injections. The diagnosis of Azoospermia (Oligospermia) will be established on the basis of two and more semen analysis evaluations done at separate occasions and detailed history taking, physical examination and investigations (blood tests include hormon levels as testosteron. follicle stimulating hormone (FSH), luteinizing hormone (LH). karyotyping and testosterone levels, and may include testicular biopsy or transrectal ultrasound if indicated. This study affect only Pretesticular and Testicular forms, without chromosomal aberration. SVF can produce a lot of cytokines ( as EGF, FGF, NGF, PDGF, VEGF, IGF, GMCSF, GCSF, TGF, Erythropoetin, TPO, BMP, HGF, GDF, Neurotrophins, MSF, SGF, GDF and growth factors) moreover the microvesicles and exosomes released by this cells can prevent cells from apoptosis and stimulate regenerative process of surrounding tissues and cells. SVF will be transplanted by an andrological surgeon through a standard surgical approach. Subjects will be monitored frequently for a total of one year after cell injection. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03762967
Study type	Interventional
Source	State-Financed Health Facility "Samara Regional Medical Center Dinasty"
Contact
Status	Enrolling by invitation
Phase	Phase 2
Start date	March 12, 2018
Completion date	December 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04675164` - Laser Assisted Sperm Selection of Viable Immotile Testicular Sperm in Azoospermic Infertile Men	N/A
Not yet recruiting	`NCT02617173` - The Effect of Low Electrical Current on Testicular Spermatocyte Count	N/A
Completed	`NCT01375062` - Obtaining Undifferentiated Cells From Testis Biopsy	N/A
Active, not recruiting	`NCT05134428` - Safety Evaluation of the ADAM System	N/A
Active, not recruiting	`NCT05866484` - Testicular Sperm Aspiration (TESA) vs. Microfluidic Sperm Separation (MSS)
Completed	`NCT00484081` - Microdissection Testicular Sperm Extraction (MicroTESE) and IVF-ICSI Outcome in Non-Obstructive Azoospermia (NOA)	N/A
Recruiting	`NCT02418832` - Testis Needle Aspiration of Sperm in Men With Azoospermia	N/A
Recruiting	`NCT02041910` - Testicular Injection of Autologous Stem Cells for Treatment of Patients With Azoospermia	Phase 1/Phase 2
Recruiting	`NCT02008799` - Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management of Azoospermia	N/A
Completed	`NCT01509482` - Insulin Resistance in Idiopathic Oligospermia and Azoospermia	N/A
Completed	`NCT02339272` - Study of Synapsis and Recombination in Male Meiosis and the Implications in Infertility	N/A
Completed	`NCT00548977` - Genetic Studies Spermatogenic Failure	N/A
Recruiting	`NCT05479474` - Platelet Rich Plasma Testis Treatment for Infertile Men	N/A
Not yet recruiting	`NCT02275169` - FSH Treatment for Non-obstructive Azoospermic Patients	Phase 3
Recruiting	`NCT00282477` - Trial to Evaluate Erectile Function, Fertility and Sperm Count in Male Cyclists Compared to Age Matched Controls	Phase 2
Recruiting	`NCT05628987` - The Association of Gut Microbiota and Spermatogenic Dysfunction
Recruiting	`NCT02544191` - GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia	Phase 2
Enrolling by invitation	`NCT02307994` - Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH	Phase 4
Completed	`NCT02414295` - Sperm Production in Kleinfelter Syndrome Patients After Mesenchymal Stem Cell Injection	N/A
Terminated	`NCT02773498` - Comparison of Medical Results of Testicular Sperm Extraction by Conventional Surgery and Microsurgical Track	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Autologous Adipose-Derived Adult Stromal Vascular Cell Administration for Male Patients With Infertility

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms